Botulinum neurotoxins: Mechanism of action and therapeutic applications

Molecular Medicine Today

Volumn 2, Issue 10, 1996, Pages 418-424

  Montecucco, Cesare ^a   Schiavo, Giampietro ^b   Tugnoli, Valeria ^d   De Grandis, Domenico ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c UNIVERSITY HOSPITAL OF FERRARA   (Italy)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; BOTULINUM TOXIN; METALLOPROTEINASE; NEUROTOXIN;

ARTICLE; BOTULISM; CHEMICAL STRUCTURE; CHEMISTRY; CLASSIFICATION; CLOSTRIDIUM BOTULINUM; DRUG EFFECT; HUMAN; METABOLISM; MUSCLE CONTRACTION; PROTEIN BINDING; SYNAPSE;

ACETYLCHOLINE; BOTULINUM TOXINS; BOTULISM; CLOSTRIDIUM BOTULINUM; HUMANS; METALLOENDOPEPTIDASES; MODELS, MOLECULAR; MUSCLE CONTRACTION; NEUROTOXINS; PROTEIN BINDING; SYNAPSES;

EID: 0030256824     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-4310(96)84845-3     Document Type: Review

References (38)

1. Smith, L.D.S. and Sugiyama, H. (1988) Botulism: the Organism, its Toxins, the Disease (2nd edn) Thomas Springfield
2. Hatheway, C.L. (1995) Botulism: the present status of the disease, Curr. Top. Microbiol. Immunol. 195, 55-75
3. Arnon, S.S. (1992) Infant Botulism, in Textbook of Pediatric Infectious Diseases (3rd edn) (Feigen, R.D. and Cherry, J.D., eds), pp. 1095-1102, W.B. Saunders & Co.
4. Sakaguchi, G. (1983) Clostridium botulinum toxins, Pharmac. Ther. 19, 165-194
5. Tacket, C.O. and Rogawski, M.A. (1989) Botulism, in Botulinum Neurotoxin and Tetanus Toxin (Simpson, L.L. ed.), pp. 351-378, Academic Press
6. Hatheway, C.L. and Dang, C. (1994) Immunogenicity of the neurotoxins of Clostridium botulinum, in Therapy with Botulinum Toxin (Jankovic, J. and Hallett, M., eds), pp. 93-107, Marcel Dekker
7. Shone, C.C. and Tranter, H.S. (1995) Growth of Clostridia and preparation of their neurotoxins, Curr. Top. Microbiol. Immunol. 195, 143-160
8. Minton, N.P. (1995) Molecular genetics of clostridial neurotoxins, Curr. Top. Microbiol. Immunol. 195, 161-191
9. Montecucco, C. and Schiavo, G. (1993) Tetanus and botulinum neurotoxins: a new family of metalloproteases, Trends Biochem. Sci. 18, 324-327
10. Montecucco, C. and Schiavo, G. (1995) The structure and function of tetanus and botulinum neurotoxins, Quart. Rev. Biophys. 28, 423-472
11. Nishiki, T. et al. (1996) The high-affinity binding of Clostridium botulinum type B neurotoxin to synaptotagmin II associated with gangliosides GT1b/GD1a, FEBS Lett. 378, 253-257
12. 125I-labeled neurotoxins with nerve terminals. I. Ultrastructure, autoradiographic localization and quantitation of distinct membrane acceptors for types A and B on motor nerves, J. Cell Biol. 103, 521-534
13. Dolly, J.O., Black, J., Williams, R.S. and Melling, J. (1984) Acceptors for botulinum neurotoxin reside on motor nerve terminals and mediate its internalization, Nature 307, 457-460
14. 2 neurotoxins, J. Pharmacol. Exp. Ther. 269, 256-262
15. Barrett, A.J., ed. (1995) Proteolytic Enzymes: Aspartic and Metallopeptidases (Methods in Enzymology Vol. 248), Academic Press
16. Rothman, J.E. (1994) Mechanisms of intracellular protein transport, Nature 372, 55-63
17. Sudhof, T.C. (1995) The synaptic vesicle cycle: a cascade of protein-protein interactions, Nature 375, 645-653
18. Hayashi, T. et al. (1994) Synaptic vesicle membrane fusion complex: action of clostridial neurotoxins on assembly, EMBO J. 13, 5051-5061
19. Pellegrini, L.L. et al. (1995) Clostridial neurotoxins compromise the stability of a low energy SNARE complex mediating NSF activation of synaptic vesicle fusion, EMBO J. 14, 4705-4713
20. Foran, P. et al. (1996) Botulinum neurotoxin C1 cleaves both syntaxin and SNAP25 in intact and permeabilized chromaffin cells: correlation with its blockade of catecholamine release, Biochemistry 35, 2630-2636
21. Osen-Sand, A. et al. (1996) Common and distinct fusion-proteins in axonal growth and transmitter release, J. Comp. Neurol. 367, 222-234
22. Williamson, L.C. et al. (1996) Clostridial neurotoxins and substrate proteolysis in intact neurons: botulinum neurotoxin C acts on SNAP-25, J. Biol. Chem. 271, 7694-7699
23. Patarnello, T. et al. (1993) Neurotransmission and secretion, Nature 364, 581-582
24. Oyler, G.A. et al. (1989) The identification of a novel synaptosomal-associated protein, SNAP-25, differently expressed by neuronal subpopulations, J. Cell Biol. 109, 3039-3052
25. Osen-Sand, A. et al. (1993) Inhibition of axonal growth by SNAP-25 antisense oligonucleotides in vitro and in vivo, Nature 364, 445-448
26. Blasi, J. et al. (1993) Botulinum neurotoxin C blocks neurotransmitter release by means of cleaving syntaxin, EMBO J. 12, 4821-4828
27. Schiavo, G. et al. (1995) Botulinum neurotoxin type C cleaves a single Lys-Ala bond within the carboxyl-terminal region of syntaxins, J. Biol. Chem. 270, 10566-10570
28. Rossetto, O. et al. (1994) SNARE motif and neurotoxin recognition, Nature 372, 415-416
29. Burgen, A.S.V., Dickens, F. and Zatman, L.J. (1949) The action of botulinum toxin on the neuro-muscular junction, J. Physiol. 109, 10-24
30. Borodic, G.E., Ferrante, R.J., Pearce, L.B. and Alderson, K. (1994) Pharmacology and histology of the therapeutic application of botulinum toxin, in Therapy with Botulinum Toxin (Jankovic, J. and Hallett, M., eds), pp. 119-157, Marcel Dekker
31. Jankovic, J. and Hallett, M., eds (1994) Therapy with Botulinum Toxin, Marcel Dekker
32. Scott, A.B. (1994) Introduction, in Therapy with Botulinum Toxin (Jankovic, J. and Hallett, M., eds), pp. vii-ix, Marcel Dekker
33. Scott, A.B. (1980) Botulinum injection into extraocular muscles as an alternative to strabismus surgery, Ophthalmology 87, 1044-1049
34. Eleopra, R. et al. The variability in the clinical effect induced by botulinum neurotoxin type A: the role of muscular activity in humans, Mov. Disord. (in press)
35. Ludlow, C.L. et al. (1992) Therapeutic use of type F botulinum toxin, New Engl. J. Med. 326, 349-350
36. Carruthers, A. and Carruthers, J.D.A. (1994) Botulinum toxin in the treatment of glabellar frown lines and other facial wrinkles, in Therapy with Botulinum Toxin (Jankovic, J. and Hallett, M., eds), pp. 577-595, Marcel Dekker
37. Gui, D. et al. (1994) Botulinum toxin for chronic anal fissure, Lancet 344, 1127-1128
38. Oguma, K. et al. Structure and function of progenitor toxins produced by Clostridium botulinum types A, C, D and E, in Biomedical Aspects of Clostridial Neurotoxins (Foster, K.A., Shone, C.C. and Hambleton, P., eds), Oxford University Press (in press)